Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA) announced today the commencement of a proposed underwritten public offering of shares of its common ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE